Yen, Swiss franc rally on global outlook risks after hawkish Powell
* Fed's Powell says risks of inflation rising
* Fed's Powell says may accelerate pace of bond taper
* Omicron risks weigh on market sentiment
* Graphic: World FX rates Link
By Caroline Valetkevitch and Gertrude Chavez-Dreyfuss
NEW YORK, Nov 30 (Reuters) - The safe-haven yen and Swiss Franc gained on Tuesday, with risk appetite plummeting, as investors grew nervous about a suddenly hawkish Federal Reserve that could deliver aggressive rate hikes and derail a nascent economic recovery.
Worries about the new Omicron coronavirus variant also kept a bid in these safe-haven currencies.
The dollar, on the other hand, retreated on Tuesday after rising when Fed Chair Jerome Powell said the risk of inflation had increased and suggested retiring the term "transitory" to describe the surge in prices. He also pushed for accelerating the tapering of Fed asset purchases.
His comments suggested an urgency to undertake quick monetary policy action that financial markets may not be prepared for, analysts said.
"Overall, the risks to the short-term outlook keep on growing. Investors have always viewed the Fed as the safety net, but the Fed looks like its panicking here," said Edward Moya, senior market analyst, at OANDA in New York.
"The Fed was wrong on inflation. And now it appears they're going to rush tapering and quickly deliver rate hikes. And if the inflationary pressure remains, you could see an accelerated rate hike cycle that could threaten financial conditions."
In late trading, the dollar fell 0.4% against the yen to 113.065 yen JPY=EBS .
Against the Swiss franc, the dollar dropped 0.4% to 0.9185 francs CHF=EBS .
The dollar index =USD fell 0.3% to 95.90. It rallied earlier, while U.S. stocks fell, after Powell's hawkish remarks.
"Traders are in 'sell first and ask questions later' mode," said Karl Schamotta, chief market strategist at Cambridge Global Payments in Toronto.
Earlier, the yen and Swiss franc rose against the dollar, after Moderna's CEO said the coronavirus vaccines will likely be less effective against the Omicron variant as they have been against other variants.
Adding to the fears, drugmaker Regeneron Pharmaceuticals Inc REGN.O said on Tuesday its COVID-19 antibody treatment could be less effective against Omicron.
The warnings reinforced a view that the global economy could take longer to return to pre-pandemic levels than many had been expecting.
Against the U.S. dollar, the euro EUR=EBS rose 0.4% to$1.1335, posting its biggest three-day rising streak since December 2020.
Prior to Omicron's arrival, the main driver of currency moves was how traders perceived the different speeds at which global central banks would end pandemic-era stimulus and raise interest rates as they looked to combat rising inflation without choking off growth.
Cryptocurrencies also had a volatile trading session. Ethereum ETH=BTSP was last up 4.8% at $4,668 ETH=BTSP . Bitcoin BTC=BTSP was down 0.3% at $57,645.
Currency bid prices at 4:11PM (2111 GMT) Description
U.S. Close Pct Change
+113.8900 +112.5350 Euro/Yen
+128.6000 +127.6500 Dollar/Swiss
+0.9158 Sterling/Dollar GBP=D3
+$1.3195 Dollar/Canadian CAD=D3
World FX rates Link
Reporting by Caroline Valetkevitch and Gertrude Chavez-Dreyfuss; Additional reporting by Saikat Chatterjee
in London; Editing by Bernadette Baum and David Gregorio
Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.
All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.
Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.